Characterization of breast tumors and the tumor immune landscape in young, diverse participants of the Northern California Breast Cancer Family Registry.

e12551 Background: Racial and ethnic disparities in breast cancer mortality persist across breast cancer subtypes, and variations in immune response may contribute. Single-cell spatial profiling enables detailed insights into the tumor microenvironment. Methods: We leveraged a cohort of young, racially and ethnically diverse women enrolled from 1995-2005 in the population-based Northern California Breast Cancer Family Registry (NC-BCFR). We determined feasibility of imaging-based spatial profiling on NC-BCFR TMAs with CosMx 6K SMI single-cell spatial transcriptomics assay, evaluating 140 samples from 88 women. Cells were stained with nuclear and membrane markers, imaged, and segmented with internal algorithms. Cell-level transcriptomic data of 6519 genes were normalized across the TMA and integrated with SCTransform. Manual cell typing was performed using publicly available annotations. Cell type composition for each sample for immune, fibroblast, cancer epithelium, and normal epithelium, normalized to 100 tumor cells/sample, was validated using predictions from matched H&E stained slides annotated with the HoverNet deep learning algorithm. Spatial transcriptomics data were used to predict HER2 and hormone status (HR). The immune microenvironment was examined across race, ethnicity and breast cancer subtype. Results: Race and ethnicity of 88 NC-BCFR participants were as follows: 16 Black, 22 Asian, 34 Hispanic, and 16 non-Hispanic (NH) White women. Profiles revealed 917,804 cells with mean transcript per cell of 838 (range: 517-1141). Following QC, normalization, and integration, 867,237 cells were typed across diverse phenotypes. With cell type normalized to 100 tumor cells/sample, there was a trend toward NH White samples having increased immune infiltrate vs. other racial groups, within both SMI (NH White 158, Black 116, Hispanic 89, Asian 55.3; ANOVA p = 0.263) and HoverNet (NH White 40.2, Black 24.9, Asian 29.1, Hispanic 18.9; ANOVA p = 0.117). Samples from NH White women had higher B-cell infiltrates (ANOVA p = 0.165) and macrophage content (ANOVA p = 0.000753) compared to cores from Asian, Black, and Hispanic women. Similar trends were observed in NK-cells (ANOVA p = 0.643) and T-cell infiltrates (ANOVA p = 0.318), and tertiary lymphoid structures were identified in one sample. Conclusions: Single-cell spatial transcriptomics can characterize the tumor immune microenvironment in TMAs from the 1990s, thus leveraging a highly diverse, population-based cohort study with long-term follow-up for novel, clinically relevant discoveries.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e12551
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of breast tumors and the tumor immune landscape in young, diverse participants of the Northern California Breast Cancer Family Registry.

Clemens L. Weiss, Zhicheng Ma, Jocelyn Koo, Christina N. Curtis et al.
Journal of Clinical Oncology
Cancer Immunotherapy and Biomarkers
article

Characterization of breast tumors and the tumor immune landscape in young, diverse participants of the Northern California Breast Cancer Family Registry.

Clemens L. Weiss, Zhicheng Ma, Jocelyn Koo, Christina N. Curtis, Esther M. John, Lise Mangiante, Allison W. Kurian, Julia D. Ransohoff, Jennifer Lee Caswell-Jin, Brennan Simon, M McClure
article en

Abstract

e12551 Background: Racial and ethnic disparities in breast cancer mortality persist across breast cancer subtypes, and variations in immune response may contribute. Single-cell spatial profiling enables detailed insights into the tumor microenvironment. Methods: We leveraged a cohort of young, racially and ethnically diverse women enrolled from 1995-2005 in the population-based Northern California Breast Cancer Family Registry (NC-BCFR). We determined feasibility of imaging-based spatial profiling on NC-BCFR TMAs with CosMx 6K SMI single-cell spatial transcriptomics assay, evaluating 140 samples from 88 women. Cells were stained with nuclear and membrane markers, imaged, and segmented with internal algorithms. Cell-level transcriptomic data of 6519 genes were normalized across the TMA and integrated with SCTransform. Manual cell typing was performed using publicly available annotations. Cell type composition for each sample for immune, fibroblast, cancer epithelium, and normal epithelium, normalized to 100 tumor cells/sample, was validated using predictions from matched H&E stained slides annotated with the HoverNet deep learning algorithm. Spatial transcriptomics data were used to predict HER2 and hormone status (HR). The immune microenvironment was examined across race, ethnicity and breast cancer subtype. Results: Race and ethnicity of 88 NC-BCFR participants were as follows: 16 Black, 22 Asian, 34 Hispanic, and 16 non-Hispanic (NH) White women. Profiles revealed 917,804 cells with mean transcript per cell of 838 (range: 517-1141). Following QC, normalization, and integration, 867,237 cells were typed across diverse phenotypes. With cell type normalized to 100 tumor cells/sample, there was a trend toward NH White samples having increased immune infiltrate vs. other racial groups, within both SMI (NH White 158, Black 116, Hispanic 89, Asian 55.3; ANOVA p = 0.263) and HoverNet (NH White 40.2, Black 24.9, Asian 29.1, Hispanic 18.9; ANOVA p = 0.117). Samples from NH White women had higher B-cell infiltrates (ANOVA p = 0.165) and macrophage content (ANOVA p = 0.000753) compared to cores from Asian, Black, and Hispanic women. Similar trends were observed in NK-cells (ANOVA p = 0.643) and T-cell infiltrates (ANOVA p = 0.318), and tertiary lymphoid structures were identified in one sample. Conclusions: Single-cell spatial transcriptomics can characterize the tumor immune microenvironment in TMAs from the 1990s, thus leveraging a highly diverse, population-based cohort study with long-term follow-up for novel, clinically relevant discoveries.

Journal of Clinical OncologyVol. 43(16_suppl)
Cancer Prevention Institute of California (US), Palo Alto University (US), Stanford Health Care (US), Stanford Cancer Institute, Stanford University (US)
Openalex Percentile: Top 82%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.